Sonavex Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$3.1M
- Investors
-
28
Sonavex General Information
Description
Developer of a bioresorbable and echogenic equipment technology designed to mark at-risk blood vessels. The company's technology collects arteriovenous fistula volumetric flow rate, diameter, and depth information at the dialysis clinic to support maturation assessment, such that the site can be easily assessed for future complications, enabling healthcare providers to determine blood flow and morphology of vessels and get actionable data to deliver patient care.
Contact Information
Website
www.sonavex.comCorporate Office
- 2835 O'Donnell Street
- Suite 200
- Baltimore, MD 21224
- United States
Corporate Office
- 2835 O'Donnell Street
- Suite 200
- Baltimore, MD 21224
- United States
Sonavex Timeline
Sonavex Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 20. Later Stage VC (Series B) | 13-Jul-2026 | $3.1M | Completed | Clinical Trials - Phase 4 | ||
| 19. Later Stage VC (Series A2) | 25-Oct-2024 | Completed | Clinical Trials - Phase 4 | |||
| 18. Grant | 25-Sep-2024 | Completed | Clinical Trials - Phase 4 | |||
| 17. Secondary Transaction - Private | Completed | Clinical Trials - Phase 4 | ||||
| 16. Grant | 30-Jun-2022 | Completed | Clinical Trials - Phase 4 | |||
| 15. Grant | 25-May-2022 | Completed | Clinical Trials - Phase 4 | |||
| 14. Grant | 15-Sep-2021 | Completed | Clinical Trials - Phase 4 | |||
| 13. Accelerator/Incubator | 01-Jun-2020 | Completed | Clinical Trials - Phase 4 | |||
| 12. Debt - PPP | 15-Apr-2020 | $193K | $9.1M | Completed | Clinical Trials - Phase 4 | |
| 11. Later Stage VC (Series A1) | 31-Jan-2020 | $4.3M | $9.1M | Completed | Clinical Trials - Phase 4 |
Sonavex Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A2 | ||||||||
| Series A | 637,816 | $0.000100 | $7.04 | $7.04 | 1x | $7.04 | 18.81% | |
| Seed | 140,464 | $0.000100 | $2.37 | $2.37 | 1x | $2.37 | 4.14% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Sonavex Comparisons
Industry
Financing
Details
Sonavex Competitors (7)
One of Sonavex’s 7 competitors is Alio, a Venture Capital-Backed company based in Broomfield, CO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alio | Venture Capital-Backed | Broomfield, CO | ||||
| EchoNous | Private Equity-Backed | Redmond, WA | ||||
| HistoSonics | Private Equity-Backed | Plymouth, MN | ||||
| Synaptive Medical | Formerly VC-backed | Mississauga, Canada | ||||
| Monteris Medical | Venture Capital-Backed | Minnetonka, MN |
Sonavex Patents
Sonavex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250073398-A1 | Ultrasound blood vessel imaging and cannulation assistance systems | Pending | 05-Sep-2023 | ||
| US-20260263033-A1 | Ultrasound blood vessel imaging and cannulation assistance systems | Pending | 05-Sep-2023 | ||
| WO-2026054807-A1 | Ultrasound blood vessel imaging and cannulation assistance systems | Pending | 05-Sep-2023 | ||
| AU-2016293866-A1 | Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity | Inactive | 16-Jul-2015 | ||
| CA-2985498-A1 | Microcavity-containing polymeric medical devices for enhanced ultrasonic echogenicity | Inactive | 16-Jul-2015 | B29C44/02 |
Sonavex Signals
Sonavex Investors (28)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accelerator Venture Partners | Venture Capital | Minority | ||
| Biohealth Innovation | Corporation | Minority | ||
| GenHenn Capital | Family Office | Minority | ||
| JSTAR Capital | Venture Capital | Minority | ||
| Keiretsu Forum | Angel Group | Minority |
Sonavex FAQs
-
When was Sonavex founded?
Sonavex was founded in 2013.
-
Where is Sonavex headquartered?
Sonavex is headquartered in Baltimore, MD.
-
What is the size of Sonavex?
Sonavex has 25 total employees.
-
What industry is Sonavex in?
Sonavex’s primary industry is Diagnostic Equipment.
-
Is Sonavex a private or public company?
Sonavex is a Private company.
-
What is the current valuation of Sonavex?
The current valuation of Sonavex is .
-
What is Sonavex’s current revenue?
The current revenue for Sonavex is .
-
How much funding has Sonavex raised over time?
Sonavex has raised $27.2M.
-
Who are Sonavex’s investors?
Accelerator Venture Partners, Biohealth Innovation, GenHenn Capital, JSTAR Capital, and Keiretsu Forum are 5 of 28 investors who have invested in Sonavex.
-
Who are Sonavex’s competitors?
Alio, EchoNous, HistoSonics, Synaptive Medical, and Monteris Medical are some of the 7 competitors of Sonavex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process